We could not find any results for:
Make sure your spelling is correct or try broadening your search.
HLS Therapeutics to Host Q1 Fiscal 2024 Financial Results Conference Call Canada NewsWire TORONTO, April 25, 2024 TORONTO, April 25, 2024 /CNW/ - HLS Therapeutics Inc. ("HLS" or the...
HLS Therapeutics to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference Canada NewsWire TORONTO, April 9, 2024 TORONTO, April 9, 2024 /CNW/ - HLS Therapeutics Inc. (HLS or...
New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups Canada NewsWire TORONTO, April 8, 2024 Findings Presented...
HLS Therapeutics Announces Fiscal 2023 Financial Results Canada NewsWire TORONTO, March 14, 2024 TORONTO, March 14, 2024 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company"...
HLS Therapeutics to Host Q4 and Fiscal 2023 Financial Results Conference Call Canada NewsWire TORONTO, Feb. 29, 2024 TORONTO, Feb. 29, 2024 /CNW/ - HLS Therapeutics Inc. ("HLS" or the...
HLS Announces that Vascepa® is now reimbursed by British Columbia's Provincial Drug Plan Canada NewsWire TORONTO, Feb. 6, 2024 Public reimbursement for Vascepa is now available in...
HLS Therapeutics Announces CFO Departure Canada NewsWire TORONTO, Dec. 18, 2023 John Hanna appointed Interim CFO to replace departing CFO Tim Hendrickson TORONTO, Dec. 18, 2023 /CNW/ - HLS...
New REDUCE-IT® Analyses Show Vascepa® (Icosapent Ethyl) Associated with 29 Percent Relative Risk Reduction Compared with Placebo in Prespecified Subgroup of Patients with Metabolic...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.17 | -3.4693877551 | 4.9 | 4.95 | 4.6 | 2291 | 4.7659031 | CS |
4 | 1.06 | 28.8828337875 | 3.67 | 5.48 | 3.67 | 8322 | 4.74167085 | CS |
12 | 0.54 | 12.8878281623 | 4.19 | 5.48 | 3.52 | 11052 | 4.11155083 | CS |
26 | -0.16 | -3.27198364008 | 4.89 | 5.48 | 3.34 | 10888 | 4.00364935 | CS |
52 | -1.24 | -20.770519263 | 5.97 | 7.12 | 3.34 | 17936 | 4.92497578 | CS |
156 | -14.27 | -75.1052631579 | 19 | 20.52 | 3.34 | 19402 | 10.284619 | CS |
260 | -11.88 | -71.5231788079 | 16.61 | 25.91 | 3.34 | 31214 | 14.90472246 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions